| | By Gabrielle Masson Under President Donald Trump’s administration, the Department of Government Efficiency has reportedly terminated leases for at least 748 federal sites, including 30 FDA facilities across 23 states. |
|
|
|
By Fraiser Kansteiner Beginning in late May, BMS will lay off 223 workers in Lawrenceville, New Jersey, where the company hosts its corporate headquarters, as well as a facility for commercial and late-stage development work. Separately, the company is laying off 57 employees at a research site in California. The downsizing initiative is part of BMS’ broader effort to cut costs. |
By Gabrielle Masson After a rocky two years, money has started flowing back to biotech, with the return of the megaround exemplified in top moneymaker Xaira’s $1 billion fundraise. |
By Angus Liu A new policy from President Donald Trump aims to restrict both inbound and outbound investments related to China in certain strategic industries, including biotechnology. |
|
Tuesday, March 11, 2025 | 11am ET / 8am PT In the world of clinical trials, where precision and compliance are critical, the role of technology is more important than ever. Join us to learn how to harness the latest innovations for driving efficiencies and more streamlined experiences for patients. Register now to take a deep dive into the most pressing challenges in clinical trials today! 
|
|
By Fraiser Kansteiner Pfizer’s local manufacturing setup is already well positioned in the U.S., and the New York-based drugmaker could bring additional resources into the country if pharma import tariffs proposed by President Donald Trump take effect, the company's CEO, Albert Bourla, Ph.D., said Monday. |
By Conor Hale Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country. |
By Darren Incorvaia The molecular glue wave that first began years ago is still swelling, with Eli Lilly earmarking approximately $1.25 billion to develop new versions of the sticky molecules in collaboration with Magnet Biomedicine. |
By Andrea Park Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. |
By Angus Liu Eli Lilly has established an online portal to accept submissions for possible locations of future U.S. manufacturing sites. |
By Darren Incorvaia Private equity giant Blackstone is going big on Japan, acquiring a majority stake in the country’s leading contract research organization. |
By Darren Incorvaia Several scientists studying LGBTQ+ health issues have had their grants from the National Institutes of Health canceled effective immediately, according to a March 3 report from Stat. |
Fierce podcasts Don’t miss an episode |
| Digital health venture capital funding cooled off in 2024 following the fever pitch of investment from 2020 to 2022. But investors still see bright opportunities for the sector. |
|
|---|
|
|
|
Wednesday, March 26, 2025 | 2pm ET / 11am PT Understanding a molecule’s characteristics early in development helps minimize challenges and streamline the path to manufacturing. This webinar will explore key considerations in developability assessment, the role of in silico tools in molecular evaluation, and strategies for improving data security in the process. Register now to join us. 
|
|
Whitepaper Read about four trends that will shape the innovations, therapies, & market landscape in oncology during 2025 & beyond. Presented by Blue Matter, strategic consultants in the life sciences |
Whitepaper Discover how to revolutionize your vaccine trials with Avacare's latest white paper. Gain exclusive access to innovative, data-driven recruitment strategies that ensure diverse, efficient, and high-quality vaccine trials. Sponsored by: Avacare Clinical Research Network |
Whitepaper Develop your CAR molecule faster Sponsored by: Cell Signaling Technology |
| Submissions Open Early August |
|
|
| |
|
.png)
